Pretty standard operating procedure for the company, like Oncolix, owning the patents, product(s), in charge of processes, etc, to control flow of information. No surprise there. Biotech financiers are there for the ROI, not accolades every time news comes out.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.